Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
0 competitors in Controlled Ovarian Stimulation
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Ganirelix Gedeon Richter
Prevention of premature luteinising hormone (LH) surges in women undergoing controlled ovarian hyperstimulation (COH) for assisted reproduction techniques (ART).
View on EMAOrgalutran
The prevention of premature luteinising-hormone surges in women undergoing controlled ovarian hyperstimulation for assisted reproduction techniques. In clinical studies, Orgalutran was used with recombinant human follicle-stimulating hormone or corifollitropin alfa, the sustained follicle stimulant.
View on EMAHypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)
Benign Prostatic Hyperplasia
Infertility
Osteoporosis
Postmenopausal Osteoporosis